Allergan gets FDA approval for presbyopia eye drop

Allergan has announced the approval that its VUITY eye-drop presbyopia solution had just received the approval of the U.S. Foods & Drugs Administration (FDA). Phase 3 clinical studies have showed that VUITY, based on a formulation of pilocarpine and delivered by the company’s proprietary technology pHast, improved near and intermediate ...

To continue reading this article subscribe now

Already an Eyewear Intelligence subscriber? Sign in here.

barrier_image_OIC

Become a member today for full access from just €6,70 a week!

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation

To continue reading this article register now.